2022-11-15
2022-11-25
2022-12-11
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2023-04-17
体内基因编辑先驱断臂求生:Editas裁员20%,砍掉多款在研管线
2023-01-11
2022-11-15
2023-12-18
2023-01-01
2023-02-19
肺癌联合疗法77%疾病控制率、多款基因/RNA疗法步入临床…
2023-01-09
2023-04-15